B.Pharm Curriculum Gets Major Overhaul: AI, Machine Learning and Data Science Introduced from 2026–27

Mumbai: In a significant step towards modernising pharmacy education, the Pharmacy Council of India (PCI) has introduced a comprehensive revision of the Bachelor of Pharmacy (B.Pharm) curriculum in line with the National Education Policy (NEP). The revised syllabus will be implemented across all PCI-approved pharmacy colleges in India from the 2026–27 academic session.

The updated curriculum aims to align pharmacy education with rapid technological advancements in healthcare, including the growing use of Artificial Intelligence (AI), Machine Learning (ML), Data Science, and digital healthcare solutions. The reforms are designed to make graduates more industry-ready and better equipped for careers in research, pharmaceuticals, hospitals, healthcare technology, and regulatory organizations.

Follow MahaENews-X on: Follow MahaENews on Instagram

Under the new syllabus, students will study Python Programming for Pharmaceutical Sciences, Healthcare Psychology and Communication Skills, Data Analytics, and Biostatistics from the first year itself.

The curriculum has also introduced emerging technology subjects across later semesters. Students will be introduced to Machine Learning in the third semester, Innovation and Startup Ecosystem in the fifth semester, Artificial Intelligence in Pharmaceutical Sciences in the sixth semester, and Artificial Intelligence in Clinical Applications in the seventh semester.

The revised four-year B.Pharm programme will continue to be divided into eight semesters, requiring students to complete a minimum of 193 academic credits to earn the degree.

For admission, candidates must have completed Class 12 with English, Physics, Chemistry, and either Mathematics or Biology. Students will be required to maintain at least 75% attendance in every subject, while each semester will consist of a minimum of 90 academic working days.

The programme will continue to be taught and examined in English, and the lateral entry provision for students who have completed a Diploma in Pharmacy (D.Pharm) will remain unchanged.

The revised curriculum reflects PCI’s effort to prepare pharmacy graduates for the evolving demands of the healthcare and pharmaceutical sectors by integrating modern technologies with traditional pharmaceutical education.